About FDA

Staff

Sarah Pope Miksinski, Ph.D., Acting Director

Phone:

(301) 796-1900

Fax

(301) 796-9748

Email: 

Sarah.PopeMiksinski@fda.hhs.gov

U.S. Mail: 

10903 New Hampshire Avenue HFD-800
Silver Spring, MD 20993

Dr. Sarah Pope Miksinski is the Acting Director of the Office of New Drug Quality Assessment. She obtained her B.A. from Earlham College (1994), her doctorate in Organic Chemistry from Oklahoma State University (1999), and completed a postdoctoral fellowship from NIH (NIDA, 2000-2002). Sarah joined FDA approximately 12 years ago, serving initially as a Chemistry Reviewer for reproductive/urologic drugs. Since that time, she has held additional positions within ONDQA including Chemistry, Manufacturing and Controls Lead as well as Branch Chief and Division Director. Sarah's areas of technical expertise include the characterization of complex drug substances/products, manufacture of injectable dosage forms, and spectroscopic methodology.

 

Scott Furness, Ph.D., Deputy Office Director for Review and Operations 

Phone:

(301) 796-1900

Fax

(301) 796-9748

Email: 

Michael.Furness@fda.hhs.gov

U.S. Mail: 

10903 New Hampshire Avenue HFD-800
Silver Spring, MD 20993

Dr. Scott Furness is currently the Deputy Office Director for Review and Operations in the Office of New Drug Quality Assessment at the US Food and Drug Administration. Prior to joining ONDQA in 2013, he served as the Director of the Division of Nonprescription Regulation Development (DNRD), in the Office of New Drug (OND) Office of Drug Evaluation IV (ODE IV, formerly the Office of Nonprescription Products). Prior to joining ODE IV in 2007, Scott served as a Chemistry Reviewer and Team Leader in the Office of Generic Drugs (OGD). Scott has coauthored a number of peer-reviewed publications relating to Pharmaceutical Solid Polymorphism and Impurities.  Before coming to FDA/CDER in 2000, Scott was an NIH Postdoctoral Fellow in the Laboratory of Medicinal Chemistry in the National Institute of Diabetes and Digestive and Kidney Diseases. While at NIH, he worked on the design, synthesis, and pharmacological evaluation of molecules directed at various central and peripheral drug receptors. Scott received his undergraduate degree in chemistry from Virginia Tech and his Ph.D. in synthetic organic chemistry from the University of Georgia.

 

Ramesh K. Sood, Ph.D., Acting Deputy Office Director for Science and Policy 

Phone:

(301) 796-1900

Fax

(301) 796-9748

Email: 

Ramesh.Sood@fda.hhs.gov

U.S. Mail: 

10903 New Hampshire Avenue HFD-800
Silver Spring, MD 20993

Dr. Ramesh K. Sood is currently Acting Deputy Office Director for Science and Policy and Division Director (Acting) in the Office of New Drug Quality Assessment, Food and Drug Administration, Silver Spring. He received his Ph.D. in organic chemistry from the Queen’s University, Kingston, Canada. Prior to joining the FDA, Ramesh has worked for several years in biopharmaceutical industry. He joined the Food and Drug Administration in 2001 as a review chemist. During his period at the FDA, he has held positions of a Team Leader and a Branch Chief in the Office of New Drug Quality Assessment. 

Page Last Updated: 12/23/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.